QQ
微信
| | 英文名称 | | 中文名称 | | CAS |
|---|---|---|
| Tislelizumab | 替雷利珠单抗 | 1858168-59-8 |
| Ladiratuzumab | LADIRATUZUMAB (ANTI-SLC39A6) | 1629760-28-6 |
| Narsoplimab | NARSOPLIMAB (纳索利单抗 ) | 2108782-45-0 |
| Netakimab | Netakimab | 1796570-08-5 |
| Cetrelimab | Cetrelimab | 2050478-92-5 |
| Enapotamab Vedotin | Enapotamab Vedotin | 1912424-97-5 |
| Omburtamab | 奥博妥单抗 | 1895083-75-6 |
| Nimacimab | NIMACIMAB (尼迈西单抗 ) | 2098636-09-8 |
| Nidanilimab | NIDANILIMAB (尼达利单抗 ) | 2171061-85-9 |
| Cosibelimab | COSIBELIMAB (柯希利单抗 ) | 2216751-26-5 |
| Ganitumab | GANITUMAB ( 加尼妥单抗 ) | 905703-97-1 |
| Anrukinzumab | ANRUKINZUMAB ( 安芦组单抗 ) | 910649-32-0 |
| Oportuzumab Monatox | Oportuzumab Monatox | 945228-48-8 |
| Figitumumab | FIGITUMUMAB ( 芬妥木单抗 ) | 943453-46-1 |
| Ensituximab | ENSITUXIMAB ( 恩妥昔单抗 ) | 1092658-06-4 |
| Atinumab | ATINUMAB ( 阿替奴单抗 ) | 1226761-65-4 |
| Crenezumab | Crenezumab | 1095207-05-8 |
| Tabalumab | TABALUMAB ( 他贝芦单抗 ) | 1143503-67-6 |
| Orticumab | Orticumab | 1314241-10-5 |
| Pinatuzumab Vedotin | Pinatuzumab Vedotin | 1313706-14-7 |
